Table 2.
Percentage of physicians who believe that available treatments at the time did not adequately treat common specific symptoms of FM*
| PCP (n=639)a, % | Rheumatologist (n=192)b, % | Neurologist (n=158)c, % | Psychiatrist (n=129)d, % | Pain specialist (n=176)e, % | |
|---|---|---|---|---|---|
|
Fatigue |
51 |
54 |
49 |
50 |
51 |
|
Chronic widespread pain |
50 |
60a |
51 |
56 |
57 |
|
Difficulty concentrating |
44 |
47 |
44 |
40 |
47 |
|
Numbness/tingling |
40 |
38 |
35 |
43 |
40 |
|
Feelings of depression |
37 |
38 |
40 |
33 |
42 |
|
Stiffness |
35 |
33 |
37 |
37 |
39 |
|
Problems sleeping |
31 |
28 |
34 |
23 |
36d |
|
Feelings of anxiety |
31 |
34 |
27 |
25 |
29 |
| Headaches | 28 | 30 | 31 | 22 | 25 |
*At the time the survey was conducted no medications for FM were licensed in any of the countries surveyed.
a, b, c, d, and e indicate statistically significant difference (P<0.05) among the subgroups (i.e., physician specialties) being analyzed.